Quote Originally Posted by ay2012 View Post
I understand the incentives of a corporation, thank you. And they are free to develop, test and market the drug however they'd like. I agree business is business.
But U2FP has invited them to W2W and is giving them a platform at an event dedicated to CURING PARALYSIS FROM CHRONIC SPINAL CORD INJURY. I imagine Richard Garr is going to the event to try to communicate how his company and product fits into this. The opinion of the scientists is that the cells alone won't do it. You've all rightly indicated that it may not be their strategy to push the neural stem cells past safety. It would be nice if someone would ask the questions to verify that their strategy is just that. Something tells me such an honest appraisal of the situation won't appear on the website or the CEO blog.
Also, why dont you try to come to W2W?